Annexon Inc (ANNX) Stock Analysis
Verdict: WATCH (do not buy)
Binary Q4 2026 Phase 3 readouts offer high upside, but $186M annual cash burn and sharp technical sell-off create significant near-term risk.
Investment score: 44/100
Analysis as of
Is Annexon Inc stock worth reviewing? AI model thesis
The AI model rates Annexon as a WATCH (Score: 44/100). While the company boasts transformational late-stage clinical candidates (tanruprubart and vonaprument) and an extended runway into 2028, ongoing heavy cash burn and significant technical downtrend outweigh near-term risk-adjusted potential prior to Q4 2026 data readouts.
7-factor investment score
- Valuation: 30/100 (weight 20%)
- Financial Health: 55/100 (weight 15%)
- Technical Momentum: 25/100 (weight 15%)
- Earnings Quality: 40/100 (weight 15%)
- Insider Sentiment: 70/100 (weight 10%)
- Analyst Consensus: 75/100 (weight 10%)
- Risk-Adjusted Return: 35/100 (weight 15%)
Annexon Inc opportunities and risks
What speaks for ANNX
- Tanruprubart (ANX005) BLA Submission in Q4 2026
What speaks against ANNX
- Binary Phase 3 Clinical Readout Failure in Geographic Atrophy
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| ANNX | n/a | 0.0x | n/a | 0.0% | 0.0% | -34.6% |
| SANA | n/a | 0.0x | n/a | 0.0% | 0.0% | -19.9% |
| FDMT | n/a | 7.3x | n/a | 42.0% | -194.7% | -23.4% |
| IMMX | n/a | 0.0x | n/a | 0.0% | 0.0% | -5.9% |
| ACHV | n/a | 0.0x | n/a | 0.0% | 0.0% | -7.2% |
| MDXG | 110.8x | 1.8x | 21.6x | 78.8% | 1.8% | 6.3% |
| Peer median | n/a | 0.0x | n/a | 0.0% | 0.0% | -7.2% |
Frequently asked questions about Annexon Inc (ANNX)
Is ANNX stock a good investment?
The cached TradeMates AI model rates Annexon Inc as WATCH (do not buy) with an investment score of 44/100. The AI model rates Annexon as a WATCH (Score: 44/100). While the company boasts transformational late-stage clinical candidates (tanruprubart and vonaprument) and an extended runway into 2028, ongoing heavy cash burn and significant technical downtrend outweigh near-term risk-adjusted potential prior to Q4 2026 data readouts. This is algorithmic model output, not personal investment advice.
Is ANNX stock a buy?
The TradeMates model verdict for ANNX is WATCH (do not buy) with an investment score of 44/100. Treat this as a model signal to review, not a personal buy recommendation.